Waldencast narrows to Milk Makeup after Obagi sale as Milk revenue plunges
Waldencast sold Obagi and now focuses on Milk Makeup, which saw net revenue fall 57.1 percent to $26.1 million in the first half of 2026. The company took a $52.3 million goodwill impairment charge on Milk and plans to delist from Nasdaq and trade over the counter under the ticker MLKM. This leaves Waldencast with a single struggling brand.
Where this came from. One outlet reported this. We read it, then wrote the sixty words above.